A Stony Brook company whose human COVID-19 vaccine was repurposed to treat cats has pivoted to a more promising animal market: mink farms. Applied DNA Sciences Inc. expects to begin the new animal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results